National
U.S. Congress moves against anti-gay Uganda bill
U.S. Sen. Susan Collins, who’s supporting a resolution condemning a harshly anti-gay Uganda bill, said the measure is ‘appalling and I want to convey that.’ (DC Agenda photo by Michael Key)
Lawmakers in both chambers of Congress last week introduced resolutions condemning a harshly anti-gay bill pending in Uganda.
In the Senate, the sponsor of the resolution is Sen. Russ Feingold (D-Wis.), chair of the Foreign Relations African Affairs subcommittee. The sponsor of the resolution in the House is Rep. Howard Berman (D-Calif.), chair of the House Foreign Affairs Committee.
Homosexual acts are already illegal in Uganda, but the African nation’s pending legislation would, among other things, institute the death penalty in some cases for LGBT people and require citizens to report LGBT people to the police.
In a statement, Berman said passage of the Uganda bill could interfere with efforts to address the HIV/AIDS epidemic in the country.
“The proposed Ugandan bill not only threatens human rights, it also reverses so many of the gains that Uganda has made in the fight against HIV/AIDS,” he said. “This issue has united leaders of different political and religious views in Uganda and worldwide in one common belief in the rights of all human beings regardless of sexual orientation.”
The Senate resolution goes further than the House measure, calling for repeal of the criminalization of homosexuality in other countries and urging the State Department to closely monitor human rights abuses against LGBT people abroad.
Both resolutions enjoy considerable support from lawmakers of both parties. More than three-dozen House members joined to introduce the House measure, including gay Reps. Barney Frank (D-Mass.) and Tammy Baldwin (D-Wis.), as well as Congressional Black Caucus Chair Rep. Barbara Lee (D-Calif.). On the other side of the aisle, Rep. Ileana Ros-Lehtinen (R-Fla.) has signed on in support.
Lynne Weil, spokesperson for the House Foreign Affairs Committee, said the panel would make a decision on how to proceed with the resolution in the coming weeks.
For the Senate resolution, a politically diverse group of lawmakers are co-sponsors. In addition to Sen. Ben Cardin (D-Md.), original co-sponsors included Sens. Tom Coburn (R-Okla.) and Susan Collins (R-Maine).
Collins told DC Agenda she was interested in co-sponsoring the Senate resolution because of the draconian nature of Uganda’s bill.
“This is an appalling proposal in Uganda, which suggests the death penalty for homosexual acts,” she said. “I think it’s self-evident that I would think that that’s appalling and I want to convey that.”
Mark Bromley, chair of the Council for Global Equality, said bipartisan support for the resolution shows the tremendous attention that Uganda’s bill has received from human rights advocates.
“Senators from across the ideological divide are expressing that this is a significant human rights issue and an issue that the U.S. government takes seriously,” he said.
Bromley said the resolutions are “not simply symbolic” and have a chance of passing in both chambers of Congress.
On Monday, another lawmaker expressed opposition to Uganda’s bill during a demonstration outside the Uganda mission to the United Nations in New York City, according to Human Rights First.
Rep. Carolyn Maloney (D-N.Y.) said in a statement that the “officially sanctioned bigotry” in the legislation is “profoundly disturbing.”
“It constitutes a gross violation of the universal values of individual liberty and human rights,” she said. “Such a measure goes far beyond ugliness and ignorance: it is hate in its rawest form, and it has no place in the laws of any nation.”
Maloney was joined at the demonstration by about two dozen other participants, including members of Human Rights First, Immigration Equality, the International Gay & Lesbian Human Rights Commission and Human Rights Watch. The lawmaker called on Ugandan officials to meet with human rights groups to discuss the widespread opposition to the bill.
Paul LeGendre, director of the Fighting Discrimination Program at Human Rights Watch, said during the demonstration that Uganda’s bill “represents one of the harshest discriminatory measures ever proposed in any country.”
“This bill would have disastrous effects for gay men and women in Uganda, would aggravate an already alarming trend of criminalization of homosexuality across Africa, and could spur Ugandan homosexuals to flee this persecution by attempting to seek refuge outside of the country,” he said. “The international community must continue to voice its concern to the Ugandan authorities until the text of this bill is shredded and removed from consideration.”
The path for the legislation in Uganda parliament remains in question. Bromley said he’s “been hearing different stories” about the timeline for the bill, but that it’s likely to come up for debate in the next few weeks.
“To be honest, my suspicion is that the president of Uganda would like to see this legislation disappear and so my hope is that they will sort of stretch out the consideration so that eventually the interest dies down a bit, and then, perhaps they can move from it,” he said.
Obama, Clinton stand against Uganda bill
In related news, President Obama and Secretary of State Hillary Clinton reiterated their opposition last week to the Uganda legislation in remarks at the National Prayer Breakfast in D.C.
Clinton said she contacted Ugandan President Yoweri Museveni to directly express U.S. concerns about the anti-gay legislation.
“I recently called President Museveni, whom I have known through the prayer breakfast, and expressed the strongest concerns about a law being considered in the parliament of Uganda,” she said.
Obama called the Uganda measure an “odious” bill in remarks that more broadly drew attention to LGBT issues.
“We may disagree about gay marriage, but surely we can agree that it is unconscionable to target gays and lesbians for who they are — whether it’s here in the United States or, as Hillary mentioned, more extremely in odious laws that are being proposed most recently in Uganda,” he said.
Obama and Clinton’s participation at the National Prayer Breakfast was somewhat controversial because the evangelical Christian group staging the event, known as “The Family,” has ties to Ugandan officials. David Mahati, the author of the anti-gay bill in the country’s parliament, attended past National Prayer Breakfasts, but didn’t attend this year’s event.
LGBT activists praised Obama and Clinton for their remarks. Wayne Besen, executive director of Truth Wins Out, commended Obama for “having the courage to confront those responsible for the heinous anti-gay bill in Uganda.”
Besen helped to coordinate the American Prayer Hour, protest events involving pro-LGBT religious leaders intended to counter the National Prayer Breakfast. The counter-event took place in 20 cities across the country.
“We hope that the president’s laudable stand makes it clear to Family members in the United States and Uganda that the world is watching,” Besen said in a statement. “Religion can no longer be used to justify bigotry, intolerance and persecution anywhere on the face of the Earth.”
Bromley also said Obama and Clinton’s decision to speak out against the Uganda legislation during the National Prayer Breakfast was a “very positive” move because of the religious nature of the event.
“I think clearly there were some religious voices behind the bill in Uganda, so we thought it was incredibly powerful that the president and first lady attended the breakfast, spoke from a personal perspective about religion and how this bill from any religious perspective just is unacceptable,” Bromley said.
But according to the French news agency Agence France-Presse, Uganda’s Ethics Minister James Buturo responded angrily to Obama and Clinton for speaking out against the Uganda bill.
“Somebody should tell President Obama that the parliament is doing its legislative duty in the interest of the people of Uganda,” Buturo was quoted as saying. “We cannot tell the Senate what to do. We cannot tell Congress what to do. So why do they feel that they can tell us what we should do in the interest of our people?”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Protecting the trans community is not optional for elected allies and candidates
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
